Literature DB >> 25112900

Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.

Su Jin Jeong1, Sang Sun Yoon2, Il Kwon Bae3, Seok Hoon Jeong4, June Myung Kim1, Kyungwon Lee5.   

Abstract

The incidence of carbapenem-resistant Pseudomonas aeruginosa (CRPA) bacteremia has increased in recent years, and infections caused by CRPA result in higher mortality than those caused by susceptible strains. This study was performed to evaluate the risk factors for mortality and to study the impact of virulence factors and bacterial strains on clinical outcomes in patients with CRPA bacteremia. Data on 63 episodes of CRPA bacteremia that have occurred between January 1, 2007, and December 31, 2009, in a teaching hospital (2000 beds) in Seoul, Korea, were analyzed. The Acute Physiology and Chronic Health Evaluation II (APACHE II) score at the time of CRPA bacteremia and the capacity of CRPA to form biofilm were independent predictive factors for mortality in patients with CRPA bacteremia. In addition, the biofilm-forming ability and elastase activity of strains were correlated with APACHE II scores to measure the severity of disease and estimate predicted mortality in the patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenem-resistant Pseudomonas aeruginosa; Mortality; Pseudomonas aeruginosa bloodstream infection; Virulence factors

Mesh:

Substances:

Year:  2014        PMID: 25112900     DOI: 10.1016/j.diagmicrobio.2014.07.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

1.  Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.

Authors:  Q Wang; Y Zhang; X Yao; H Xian; Y Liu; H Li; H Chen; X Wang; R Wang; C Zhao; B Cao; H Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-11       Impact factor: 3.267

2.  Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure.

Authors:  Deanna J Buehrle; Ryan K Shields; Lloyd G Clarke; Brian A Potoski; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

3.  MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.

Authors:  Cédric Bretonnière; Adeline Maitte; Jocelyne Caillon; Gilles Potel; David Boutoille; Cédric Jacqueline; Christophe Guitton
Journal:  J Antibiot (Tokyo)       Date:  2016-03-30       Impact factor: 2.649

4.  Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea.

Authors:  Jun Sung Hong; Jung Ok Kim; Hyukmin Lee; Il Kwon Bae; Seok Hoon Jeong; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-03-30

Review 5.  How to manage Pseudomonas aeruginosa infections.

Authors:  Matteo Bassetti; Antonio Vena; Antony Croxatto; Elda Righi; Benoit Guery
Journal:  Drugs Context       Date:  2018-05-29

6.  Increased Virulence of Bloodstream Over Peripheral Isolates of P. aeruginosa Identified Through Post-transcriptional Regulation of Virulence Factors.

Authors:  Caitríona Hickey; Bettina Schaible; Scott Nguyen; Daniel Hurley; Shabarinath Srikumar; Séamus Fanning; Eric Brown; Bianca Crifo; David Matallanas; Siobhán McClean; Cormac T Taylor; Kirsten Schaffer
Journal:  Front Cell Infect Microbiol       Date:  2018-10-26       Impact factor: 5.293

7.  [Nosocomial infections caused by multiresistant Pseudomonas aeruginosa (carbapenems included): predictive and prognostic factors. A prospective study (2016-2017))].

Authors:  A Hernández; G Yagüe; E García Vázquez; M Simón; L Moreno Parrado; M Canteras; J Gómez
Journal:  Rev Esp Quimioter       Date:  2018-03-21       Impact factor: 1.553

Review 8.  Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections.

Authors:  Letizia Romeo; Renato Iori; Patrick Rollin; Placido Bramanti; Emanuela Mazzon
Journal:  Molecules       Date:  2018-03-09       Impact factor: 4.411

9.  Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities.

Authors:  S Zhao; S Kennedy; M R Perry; J Wilson; M Chase-Topping; E Anderson; M E J Woolhouse; M Lockhart
Journal:  J Hosp Infect       Date:  2021-02-08       Impact factor: 3.926

10.  A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections.

Authors:  Qingyi Shi; Chen Huang; Tingting Xiao; Zhenzhu Wu; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2019-04-25       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.